Investment of £226 million to help UK to 'lead the world in fighting cancer'

30 November 2016
cancer-research-uk-big-1

Cancer Research UK (CRUK), the world’s leading charity researching the disease, has made its largest ever investment into its network of centers across the country.

Some £190 million ($237 million) has been committed to 13 CRUK centers over the next five years, while the charity and the UK’s Department of Health are investing a further £36 million into 18 Experimental Cancer Medicine Centers (ECMCs) for adult patients and also a network sites for children.

"This is particularly important for hard-to-treat cancers like pancreatic, oesophageal, lung and brain tumours"

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical